AMGEN INC (AMGN) › Cost of RevenueAMGEN INC (AMGN) — Cost of RevenueAnnual figures by period end, from SEC filings.2016-12-31: $4.16B2017-12-31: $4.07B2018-12-31: $4.10B2019-12-31: $4.36B2020-12-31: $6.16B2021-12-31: $6.45B2022-12-31: $6.41B2023-12-31: $8.45B2024-12-31: $12.86B2025-12-31: $12.04B$12.04B2016-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$12.04B-6.4%2026-02-13From 2025-01-012024-12-31$12.86B+52.1%2026-02-13From 2024-01-012023-12-31$8.45B+31.9%2026-02-13From 2023-01-012022-12-31$6.41B-0.7%2025-02-14From 2022-01-012021-12-31$6.45B+4.8%2024-02-14From 2021-01-012020-12-31$6.16B+41.4%2023-02-09From 2020-01-012019-12-31$4.36B+6.2%2022-02-16From 2019-01-012018-12-31$4.10B+0.8%2021-02-09From 2018-01-012017-12-31$4.07B-2.2%2020-02-12From 2017-01-012016-12-31$4.16B—2019-02-13From 2016-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)